Company Data
Tempest Therapeutics Inc.
Ticker
TPST
Current Price
$2.72 2.64%
Market Cap
$13.4M
Price Target
Refer to Report
Volume
92.2K
52wk Range
$2.4 - $13.13
Overview
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.